Despite challenges of resolution, standardization, and data complexity, spatial proteomics is advancing rapidly. Together with frontier technologies such as quantum computing, live imaging, and organoid integration, it is driving breakthroughs in cancer diagnosis, personalized immunotherapy, and drug development.
Wang et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: